Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$3.90
+0 (+0%)
At Close: May 15, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Aileron to Present Nonclinical Myelopreservation Data for ALRN-6924 at the 2019 AACR-NCI-EORTC Conference on October 29th

 12:00pm, Monday, 21'st Oct 2019
Nonclinical research showed that ALRN-6924 prevented the toxic side effects of chemotherapy in normal cells without inhibiting the anti-cancer activity of chemotherapy..

Aileron Therapeutics Announces the Initiation of Patient Treatment in its First Clinical Ph1b/2 Trial of ALRN-6924 as a Myelopreservation Agent

 12:30pm, Wednesday, 16'th Oct 2019
Treatment uses a precision-medicine strategy to prevent the toxic side-effects of chemotherapy in patients with p53-mutated cancer, representing approximately 50% of all patients with cancer. Managem
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE